Skip to main content
logo
GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
75.13
+0.64 (0.86%)
At close: Oct 8, 2025, 4:00 PM EDT
75.10
-0.03 (-0.04%)
After-hours: Oct 8, 2025, 7:46 PM EDT

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Product Revenue
13.20B13.08B
Log In
Log In
Log In
Upgrade
Service Revenue
6.76B6.60B
Log In
Log In
Log In
Upgrade
Revenue (Other)
-1.00M-
Log In
Log In
Log In
Upgrade
Revenue (Total)
19.97B19.67B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Imaging Revenue (Post-Q2 2024)
8.97B8.86B
Log In
Log In
Log In
Upgrade
Advanced Visualization Solutions (AVS) Revenue
5.18B5.13B
Log In
Log In
Log In
Upgrade
Patient Care Solutions (PCS) Revenue
3.14B3.13B
Log In
Log In
Log In
Upgrade
Pharmaceutical Diagnostics (PDx) Revenue
2.63B2.51B
Log In
Log In
Log In
Upgrade
Other Revenue
47.00M52.00M
Log In
Log In
Log In
Upgrade
Revenue (Total)
19.97B19.67B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 3

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Patient Care Solutions (PCS) Revenue
3.14B3.13B
Log In
Log In
Log In
Upgrade
Pharmaceutical Diagnostics (PDx) Revenue
2.63B2.51B
Log In
Log In
Log In
Upgrade
Other Revenue
47.00M52.00M
Log In
Log In
Log In
Upgrade
Imaging Revenue
--
Log In
Log In
Log In
Upgrade
Ultrasound Revenue
--
Log In
Log In
Log In
Upgrade
Revenue (Total)
19.97B19.67B
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
USCAN Revenue
9.22B8.98B
Log In
Log In
Log In
Upgrade
EMEA Revenue
5.11B5.05B
Log In
Log In
Log In
Upgrade
China Revenue
2.34B2.36B
Log In
Log In
Log In
Upgrade
Rest of World Revenue
3.30B3.28B
Log In
Log In
Log In
Upgrade
Revenue (Other)
-3.00M-
Log In
Log In
Log In
Upgrade
Revenue (Total)
19.97B19.67B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Imaging EBIT (Post-Q2 2024)
976.00M962.00M
Log In
Log In
Log In
Upgrade
Advanced Visualization Solutions (AVS) EBIT
1.13B1.12B
Log In
Log In
Log In
Upgrade
Patient Care Solutions (PCS) Segment EBIT
296.00M347.00M
Log In
Log In
Log In
Upgrade
Pharmaceutical Diagnostics (PDx) Segment EBIT
823.00M783.00M
Log In
Log In
Log In
Upgrade
Other Segment EBIT
5.00M2.00M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-478.00M-587.00M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
2.76B2.63B
Log In
Log In
Log In
Upgrade

EBIT 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Patient Care Solutions (PCS) Segment EBIT
296.00M347.00M
Log In
Log In
Log In
Upgrade
Pharmaceutical Diagnostics (PDx) Segment EBIT
823.00M783.00M
Log In
Log In
Log In
Upgrade
Other Segment EBIT
5.00M2.00M
Log In
Log In
Log In
Upgrade
Imaging Segment EBIT
--
Log In
Log In
Log In
Upgrade
Ultrasound Segment EBIT
--
Log In
Log In
Log In
Upgrade
Operating Income (Total)
2.76B2.63B
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Products Remaining Performance Obligations (RPO)
4.81B4.76B
Log In
Log In
Log In
Upgrade
Services Remaining Performance Obligations (RPO)
10.50B9.74B
Log In
Log In
Log In
Upgrade
Total Remaining Performance Obligations (RPO)
15.30B14.49B
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.